Live Chat

Actos: The Big Risk in the Little Pill

For some Type 2 diabetes patients, Actos (pioglitazone) represents long awaited hope in the fight against diabetes. However, for Type 2 diabetes patients who take pioglitazone-based drugs like Actoplus Met, Actos, and Duetact and ultimately experience symptoms of bladder problems like stomach pain, loss of appetite, vomiting, nausea, dark urine, or unusual bleeding, pioglitazone treatments may represent more detriment than benefit.

 

In several tragic cases, longer-term Actos patients have contracted bladder cancer and similar bladder-related diseases as a result of their exposure to pioglitazone. To make matters worse, incomplete or ineffective warnings have left these patients surprised at the results of exposure to a medication in which they put so much hope.

 

Do you have questions about whether your current bladder-related illness may be linked to your long-term Actos prescription? The attorneys at the law firm of Fears Nachawati can help you answer these questions and establish whether your legal rights were violated. Talk to us today to get started down your road to recovery. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. Let us help!

Categories
Drug Litigation

Actos: The Big Risk in the Little Pill